Abstract
PurposeInvestigation of the efficacy and safety of 12 months of topical tacrolimus 0.03% ointment treatment against the subepithelial infiltrates (SEIs) due to adenoviral keratoconjunctivitis (AKC) resisting at least 2 years...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have